Sirona Financial Statements From 2010 to 2024
| SRBCF Stock | USD 0.05 0 9.89% |
Check Sirona Biochem financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sirona Biochem's main balance sheet or income statement drivers, such as , as well as many indicators such as . Sirona financial statements analysis is a perfect complement when working with Sirona Biochem Valuation or Volatility modules.
Sirona |
Sirona Biochem Corp Company Return On Equity Analysis
Sirona Biochem's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Sirona Biochem Return On Equity | -35.56 |
Most of Sirona Biochem's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sirona Biochem Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Sirona Biochem Corp has a Return On Equity of -35.557. This is 48.34% higher than that of the Biotechnology sector and 2.48% lower than that of the Health Care industry. The return on equity for all United States stocks is notably higher than that of the company.
Sirona Biochem Corp Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Sirona Biochem's current stock value. Our valuation model uses many indicators to compare Sirona Biochem value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Sirona Biochem competition to find correlations between indicators driving Sirona Biochem's intrinsic value. More Info.Sirona Biochem Corp is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Sirona Biochem's earnings, one of the primary drivers of an investment's value.About Sirona Biochem Financial Statements
Sirona Biochem stakeholders use historical fundamental indicators, such as Sirona Biochem's revenue or net income, to determine how well the company is positioned to perform in the future. Although Sirona Biochem investors may analyze each financial statement separately, they are all interrelated. For example, changes in Sirona Biochem's assets and liabilities are reflected in the revenues and expenses on Sirona Biochem's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Sirona Biochem Corp. Please read more on our technical analysis and fundamental analysis pages.
Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. The company was incorporated in 2006 and is headquartered in Vancouver, Canada. Sirona Biochem is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
Other Information on Investing in Sirona Pink Sheet
Sirona Biochem financial ratios help investors to determine whether Sirona Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sirona with respect to the benefits of owning Sirona Biochem security.